Your 12–24-month pharmacy exit roadmap

A staged preparation plan with clear outputs and decision points. Adapt the timetable to your business and goals.

Educational owner resource. Read the cited sources and obtain advice for your circumstances.

Use this roadmap as a working plan

This is an educational preparation framework, not a guaranteed sale timetable or a substitute for legal, tax, regulatory or valuation advice. Start at the stage that reflects your current readiness. You can complete parts concurrently; do not delay a necessary decision merely to match a suggested month. BDC’s transition guidance supports planning for the handover and potential continued seller involvement. Business Development Bank of Canada

Keep a one-page action register with the task, responsible person, due date, supporting evidence and decision needed. Revisit it monthly. The useful measure of progress is a resolved dependency or a reliable document, not the number of files collected.

Months 24–18: clarify the owner’s destination

Write down the exit date you prefer, the work you would accept after closing and the outcomes you want for staff and the community. With your accountant and financial advisor, distinguish desired personal cash from operating value and gross transaction price. Set boundaries around vendor financing, contingent payments and retained equity before negotiating.

Build a confidential advisor team with pharmacy-relevant experience. Agree scope, fees, responsibilities and communication. Review ownership, tax and family circumstances early enough to receive advice; this guide does not assume a restructuring is needed or that tax relief is available.

Output: written owner priorities and timetable.
Output: advisor roles and engagement scope.
Decision: external sale, internal succession or another path to investigate.

Months 18–12: make earnings and operations understandable

Collect three years of financials and current results. Build the normalization schedule, with evidence for each positive and negative adjustment. Record owner hours and responsibilities, estimate appropriate replacement coverage and explain accounting/reporting differences. Review inventory quality and recurring investment needs with the relevant advisors.

Gather the premises lease and material agreements. Ask counsel to identify renewal, assignment and change-of-control dependencies. Prepare a costed staffing and relief plan; document workflows so the business can function without your daily decisions. Confirm how the proposed ownership change may affect regulatory and payer arrangements.

Output: reconciled financial package and evidence-backed draft bridge.
Output: lease/contracts dependency register.
Output: realistic ongoing staffing plan.

Months 12–6: prepare a controlled sale narrative

Draft the CIM with actual facts, clear periods and open issues. Build the indexed data room and a disclosure plan. Use aggregate/redacted information for early stages and obtain qualified privacy advice before providing sensitive diligence records. Test the financial assumptions against downside scenarios rather than polishing away weaknesses.

At a private preparation review, decide whether the records, operating model and timetable support a process. If a gap is material, set a remedy and revisit date. Do not make a public launch or contact buyers simply because the planning document is complete.

Output: reviewed CIM, data-room index and information-sharing controls.
Decision: proceed, improve readiness or adjust the timetable.

Months 6–0 and handover: manage commitments

If you proceed, agree the buyer-screening approach, confidentiality steps and proposal-comparison method. Compare structure, closing cash, conditions, deferred risk and transition obligations. Obtain counsel’s review before agreeing exclusivity or an LOI. Organize diligence responses through one questions log and keep operating performance monitored.

Before closing, confirm required approvals, financing, inventory/working-capital definitions, system arrangements and handover responsibilities. Prepare a service-continuity plan and appropriately timed communications. After closing, track transition milestones and any holdback or deferred-payment obligations. If a transaction does not close, revoke access and return to the operating plan. Use the readiness quiz now, select three actions from this roadmap and bring them to a confidential planning conversation.

Continue reading

Pharmacy financial figures: gross profit, gross margin, NOI and EBITDA

Pharmacy share or asset purchase agreement: what sellers should expect

Selling a pharmacy in Canada: what happens from an accepted offer to closing?

Sources and context

PIPEDA, section 7.2: business transactions
Conditional federal business-transaction provisions. Applicability and provincial health-information requirements must be reviewed; an NDA alone does not satisfy every condition. Accessed 2026-10-14.

Purchasing a Community Pharmacy
Ontario-specific process. Guidance states at least 45 days for a complete accreditation application, not a promised approval time. Corporate amendments/share changes may require a different route.

8 tips to ensure a smooth transition when selling your business
Generic planning and seller-involvement guidance; no guaranteed pharmacy sale timetable.

Browse all articles and exit guides →

Plan your next conversation

Smith & Bederman Advisory Group supports independent Canadian pharmacy owners with sales, acquisitions, valuation and succession planning.

Explore valuation and EBITDA tools · Check exit readiness · Book a confidential consultation

Calculator access, full buyer profiles and downloads are available through the Resource Centre’s access form.